In antibody medicine for the treatment of metastatic melanoma, the recognition of the Fc portion of IgG by macrophage CD64 is known to be essential for the elimination of antibody‐bound tumor cells in the tumor microenvironment.30 This evidence concerns the gene FCGR1A and metastatic melanoma.